What is the Historic and Current Scenario of the Cardiac Sutures Market?
The cardiac sutures market has seen considerable growth due to a variety of factors.
•There has been a significant growth in the cardiac sutures market size in the last few years. The market, valued at $1.49 billion in 2024, is projected to rise to $1.61 billion in 2025, indicating a compound annual growth rate (CAGR) of 8.5%.
The growth observed in the past is due to factors such as the progression of surgical procedures, an increase in heart disease, the popularity of minimally invasive surgeries, an aging population, and investments in research and development.
What are the Forecasted Growth and Key Factors of the Cardiac Sutures Market?
The cardiac sutures market is expected to maintain its strong growth trajectory in upcoming years.
• The market for cardiac sutures is predicted to experience robust growth in the upcoming years, increasing to "$2.31 billion by 2029, at a Compound Annual Growth Rate (CAGR) of 9.4%.
This market growth forecast can be attributed to an expansion in worldwide healthcare infrastructure, commitment to patient results and recuperation, the preference and specialization of surgeons, adherence to regulations and rigorous standards, and an elevated demand for biodegradable sutures. The forecast period is expected to see the rise of significant trends like the incorporation of nanotechnology, the assistance of robotic surgeries, sutures for structural heart procedures, biodegradable sutures, and improved suture coatings.
What Are The Leading Drivers Of Growth In The Cardiac Sutures Market?
An increasing rate of cardiovascular diseases is anticipated to fuel the cardiac suture market's expansion. Cardiovascular diseases encompass disorders that influence the heart and blood vessels. Cardiac sutures perform the essential task of sealing wounds and offering the mechanical support needed to maintain closure post cardiovascular surgeries. As an example, data from the British Heart Foundation, a cardiovascular research charity in the UK, shows that in September 2024, nearly 7.6 million people in the UK suffer from heart and circulatory diseases, including approximately 4 million men and 3.6 million women. These diseases are the cause of about 27% of all UK deaths, resulting in over 170,000 deaths yearly, or roughly 480 deaths daily, averaging to one death every three minutes. Hence, the increasing occurrence of cardiovascular diseases is likely to stimulate the growth of the cardiac suture market.
How Are The Segments Defined Within The Global Cardiac Sutures Market?
The cardiac sutures market covered in this report is segmented –
1) By Type: Absorbable Sutures, Non-Absorbable Sutures
2) By Material Type: Natural, Synthetic
3) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Absorbable Sutures: Polyglactin Sutures, Polyglycolic Acid Sutures, Catgut Sutures, Monocryl Sutures, Other Absorbable Sutures
2) By Non-Absorbable Sutures: Silk Sutures, Nylon Sutures, Polyester Sutures, Polypropylene Sutures, Other Non-Absorbable Sutures
Pre-Book The Cardiac Sutures Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Expected To Influence The Growth Of The Cardiac Sutures Market?
Product development is a prominent trend on the rise in the cardiac suture market. To stay competitive, leading businesses within the cardiac suture industry are focusing on developing novel products. As an example, Able Medical Devices, a medical equipment manufacturer headquartered in the US, unveiled its Valkyrie looped sternotomy sutures in January 2023, a product primarily intended for post open heart surgical procedures. The innovative suture uses stainless steel, contrasting traditional wire sutures, to seal a patient’s chest post open heart surgery. The uniqueness of Valkyrie lies in its ability to double single wires' surface area, offering a sturdy sternal closure. It aims to minimize the potential risk of sternal dehiscence, a serious post-sternotomy complication. The product also boasts features like a looped configuration, high tensile resistance, less invasiveness, user-friendliness, and can enhance patient outcomes.
Who Are the Key Players in the Cardiac Sutures Market?
Major companies operating in the cardiac sutures market include:
• Abbott Laboratories
• Medtronic plc
• Johnson & Johnson
• B. Braun SE
• Teleflex Incorporated
• Smith & Nephew plc
• Boston Scientific Corporation
• CONMED Corporation
• Deme TECH Corporation
• Apollo Endosurgery Inc.
• Cryolife Inc.
• W. L. Gore & Associates Inc.
• Peters Surgical
• Stryker Corporation
• Ethicon Inc.
• Internacional Farmacéutica
• Sutures India
• Mellon Medical B.V.
• EndoEvolution LLC
• Surgical Specialties Corporation
• Arthrex Inc.
• Covidien Holding Inc.
• Gunze Ltd.
• Centennial Surgical Suture Ltd.
• Assut Medical Sarl
• Healthium Medtech Ltd.
• Meril Life Sciences Pvt. Ltd.
• Cardiovascular Systems Inc.
• Gore Medical Inc.
• LivaNova plc
What Is The Most Dominant Region In The Cardiac Sutures Market?
North America was the largest region in the cardiac sutures market in 2024. The regions covered in the cardiac sutures market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
